In a rare and significant milestone for an Australian-discovered therapy, Pfizer Inc has commenced a Phase 3 clinical trial to study a potential new ...

Arvinas and Pfizer plan to jointly select third party for the out-licensing and commercialization of vepdegestrant Additional ...

In a pair of studies, investigators from the lab of Huiping Liu, MD, Ph.D., associate professor of Pharmacology and of ...

During a live event, Kit Yu Lu, MD, discussed data on antibody-drug conjugates in HR+, HER2- breast cancer including the ...

Discover GLSI's HER2+ breast cancer vaccine progress, FDA Fast Track benefits, and key financial risks. Click here to read my ...

A team from Sun Yat-sen University Sun Yat-sen Memorial Hospital has identified a novel mechanism underlying platinum resistance in triple-negative breast cancer (TNBC): the circular RNA circSCAP ...

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Eli Lilly and Company, in collaboration ...

Australian scientists who discovered how to "turn off" genes that make cancer cells grow are celebrating the next phase of ...

Elissa Kalver was diagnosed with HER2-positive metastatic breast cancer at 34. Since then, she has founded a nonprofit and ...

Phase II/III data showed that advanced gastric cancer patients on anbenitamab and chemotherapy fared better than those on standard therapy.